North American Vaccine (NVX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : North American Vaccine (NVX)

NVX 1.100

+8.4%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

To: Don W Stone who wrote ()	12/10/1996 11:03:00 AM
From: andy harrison	of 35

This is in fact great news, especially for the long term. It is clear that Chiron Behring believes that NVX's DTaP and DTaP IPV is superior to the one that its own allifiate Chiron is testing. Most NVX bulls had assumed that Germany was locked up by Smithkline but now this open the doors to NVX. Once again we see NVX getting money upfront. They will also receive royalties. This will most likely open up the entire EU for NVX.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext